Search results
FIBRIPHEN 2
Measurement of fibrinogen in plasma. Detection of low fibrinogen concentrations. Detection of elevated fibrinogen concentrations (> 4g/L): In clinical situations associated with inflammation Risk factor for cardiovascular disease and thrombosis Hypofibrinogenemia, mainly associated with severe liver disease, and excessive consumption of fibrinogen (DIC, hyperfibrinolysis). Numerous variants of fibrinogen described, associated to asymptomatic cases, or to cases with bleeding and/or thrombosis.
FIBRIPHEN 1
Measurement of fibrinogen in plasma. Detection of low fibrinogen concentrations. Detection of elevated fibrinogen concentrations (> 4g/L): In clinical situations associated with inflammation Risk factor for cardiovascular disease and thrombosis Hypofibrinogenemia, mainly associated with severe liver disease, and excessive consumption of fibrinogen (DIC, hyperfibrinolysis). Numerous variants of fibrinogen described, associated to asymptomatic cases, or to cases with bleeding and/or thrombosis.
HEMOCLOT VII-X
Vitamin K deficiency. Vitamin K antagonists. Isolated factor VII or X deficiency. Accelerated clotting factor consumption (DIC).
HEMOCLOT Thrombin Time 8 (Conventional/bovine Thrombin)
Conventional thrombin time, highly sensitive to heparins and thrombin inhibitors.
HEMOCLOT Thrombin Time 2 (Conventional/bovine Thrombin)
Conventional thrombin time, highly sensitive to heparins and thrombin inhibitors.
HEMOCLOT VII-X
Vitamin K deficiency. Vitamin K antagonists. Isolated factor VII or X deficiency. Accelerated clotting factor consumption (DIC).
BIOPHEN Heparin anti-IIa (2-stages kit)
Assay proposed for the measurement of heparin anti-thrombin activity in research applications acc. to Pharmacopoeia.
BIOPHEN Heparin anti-Xa (2-stages kit)
Assay proposed for the measurement of anti-Xa heparin activity in research applications. This assay meets USP/EP requirements.
Tris NaCl EDTA BSA Buffer pH 8.40
Can be used as buffer recommended by the United States and European Pharmacopoeia for the assay of heparin anti-IIa and anti-Xa activity, verified and validated in combination with BIOPHEN ANTI-IIa (2 stages heparin assay, ref. 220005) and BIOPHEN ANTI-Xa (2 stages heparin assay, ref. 221005) kits.
Tris NaCl EDTA PEG Buffer pH 8.40
Can be used as buffer recommended by the United States and European Pharmacopoeia for the assay of heparin anti-IIa and anti-Xa activity, verified and validated in combination with BIOPHEN ANTI-IIa (2 stages heparin assay, ref. 220005) and BIOPHEN ANTI-Xa (2 stages heparin assay, ref. 221005) kits.